Portal de Periódicos da CAPES

Colonic necrosis due to sodium polystyrene sulfate (Kayexalate)

2009; Elsevier BV; Volume: 27; Issue: 6 Linguagem: Inglês

10.1016/j.ajem.2008.10.002

1532-8171

Andrew S. Bomback, John T. Woosley, Abhijit V. Kshirsagar,

Cardiac electrophysiology and arrhythmias

The rising prevalence of chronic and end-stage kidney disease is accompanied by a concomitant rising risk of hyperkalemia in these patients. Sodium polystyrene sulfonate (Kayexalate, sanofi-aventis, Bridgemater, NJ) is a commonly used treatment of hyperkalemia. We present a case of Kayexalate-induced colonic necrosis as a reminder of this rare, but potentially avoidable, toxicity of a commonly used medication.